BNET Industries

Market Cap:$148.2B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Pfizer and B.C. launch $9M collaboration to tackle cancer
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
-
Pfizer receives EC nod for Prevenar 13
-
Protalix Completes NDA Submission for taliglucerase alfa for the Treatment of Gaucher's Disease
-
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M
-
Conservationists salute two corporations
-
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV
-
2009: The Year That Was For Pfizer
-
A 2nd Loss for Pfizer in Drug Suits
-
Pfizer acquires stem cell therapies assets of Axordia
-
Standpoint Raised Its FY10 Price Target on Pfizer PFE to $24
-
ImmunoVaccine signs exclusive licence deal with Pfizer
-
Pfizer Animal Health selects Bader Rutter as agency of record
News & Analysis
Filter by
health care and pfizer inc. - All News and Analysis
Pfizer Blasted in Canada for $780K CME Program
Pfizer PFE can't catch a break in Canada right now. It's being blasted for a C$780,000 continuing medical education program it has set up through the Canadian Medical Association. Critics believe that doctor education should not be influenced by drug companies, which have a different set of interests than patients....
Pfizer to Cap Retiree Health Benefits: Out of Time? Out of Luck.
Pfizer is to cap the amount of healthcare benefits it will pay to retired employees based on their years of service with the company, according to The Day. Any retiree who hasn't worked long enough for Pfizer or who has expensive medical bills may find Pfizer's willingness to continue covering...
Lilly, Pfizer and AstraZeneca Jockeying for Position on Healthcare Reform
Eli Lilly, Pfizer, Bayer, Roche and AstraZeneca all agree on healthcare reform in the U.S.: They want to see the system changed so long as it in no way hurts their companies. by Jim Edwards
Starved of News, Press Speculates on Deals for Abbott, Pfizer and Wyeth
New Year is a slow news period, which is why the business press filled up with next-to-useless corporate strategy stories about Abbott Labs, Wyeth and Pfizer. The one thing these stories all have in common? They're long on speculation and short on substance. Let's take them one at a time....
NFL Locks Pfizer Exec Out of Player Health Meeting
Pfizer's director of health policy, Eleanor Perfetto, was locked out of a meeting about former NFL players with health problems even though she is married to an ex-player with dementia and is thus not able to represent himself. Perfetto was barred from the meeting for the 19th Century-style reason that...
Pfizer's Viagra Will Not Be Sold Over the Counter in Europe
Pfizer continues to meet resistance to its attempt to transform Viagra from a legitimate drug for a real medical condition into a party drug that promises "a more satisfying sexual experience." Today Pfizer announced that it has withdrawn its application to sell Viagra as an OTC medicine in Europe. The...
Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a presentation by Martin Mackay, President, Pfizer Global Research & Development, at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference on Wednesday, June 11th at 10:40 a.m. Pacific Daylight Saving Time.
Premier Hospitals, Healthcare Providers to Save with New Pricing on Two Pfizer Branded Antifungal Products
CHARLOTTE, N.C. -- Premier Purchasing Partners, LP, today announced a new antifungal portfolio pricing program with Pfizer Inc. that offers discounted pricing on Vfend[R] voriconazole and Eraxis[R] anidulafungin formulations, the first time Premier and Pfizer have worked together on branded products in this way.
Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a presentation by Pfizer Inc Chief Financial Officer, Frank D'Amelio, at the Citigroup Healthcare Conference on Wednesday, May 21st, at 3:30pm Eastern Daylight Saving Time.
Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a presentation by Martin Mackay, President, Pfizer Global Research & Development, at the Lehman Brothers Global Healthcare Conference on Wednesday, March 19th at 10:45 a.m. Eastern Daylight Savings Time.
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
